After a positive end to FY20, Polypipe has made an active start to FY21. The £210m acquisition of ADEY (part-funded by a c £96m gross new equity raise) is a significant step and fits well with the company’s product portfolio, market positions and its sustainable water/climate management business strategy. Including acquisition effects, we expect FY21 PBT to exceed FY19 levels, as they supplement an underlying EBIT recovery following a COVID-19-affected trough year. EPS approaches FY19 levels in FY22 (as the number of shares in issue is c 20% higher) on our estimates.

26 Feb 2021
Polypipe - Acquisitions feed into FY21 earnings recovery

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Polypipe - Acquisitions feed into FY21 earnings recovery
Genuit Group PLC (GEN:LON) | 407 40.7 2.5% | Mkt Cap: 1,014m
- Published:
26 Feb 2021 -
Author:
Toby Thorrington -
Pages:
3 -
After a positive end to FY20, Polypipe has made an active start to FY21. The £210m acquisition of ADEY (part-funded by a c £96m gross new equity raise) is a significant step and fits well with the company’s product portfolio, market positions and its sustainable water/climate management business strategy. Including acquisition effects, we expect FY21 PBT to exceed FY19 levels, as they supplement an underlying EBIT recovery following a COVID-19-affected trough year. EPS approaches FY19 levels in FY22 (as the number of shares in issue is c 20% higher) on our estimates.